z-logo
open-access-imgOpen Access
Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience
Author(s) -
Bryan G. Schwartz,
Daniel J Ludeman,
Guy S. Mayeda,
Robert A. Kloner,
Christina Economides,
Steven Burstein
Publication year - 2012
Publication title -
cardiology research
Language(s) - English
Resource type - Journals
eISSN - 1923-2837
pISSN - 1923-2829
DOI - 10.4021/cr121w
Subject(s) - impella , cardiogenic shock , medicine , cardiology , ejection fraction , percutaneous , ventricular assist device , myocardial infarction , heart failure
Patients with cardiogenic shock (CS) are routinely treated with intra-aortic balloon pumps (IABPs). The utility of 2 new percutaneous left ventricular assist devices (PLVADs), the Impella and TandemHeart, is unknown. The objective of this study was to describe the use of PLVADs for patients with CS at our institution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here